Fatty acids are synthesized de novo from acetyl-CoA and malonyl-CoA through a series of reactions mediated by acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS). In rodents, the principal fatty acid produced by FAS is palmitic acid (16:0). Sterol regulatory elementbinding proteins (SREBPs) enhance the transcription of many genes responsible for fatty acid synthesis. In transgenic mice that overexpress SREBPs in liver, the rate of fatty acid synthesis is markedly increased, owing to the activation of these biosynthetic genes, which include ATP citrate lyase, ACC, FAS, and stearoyl-CoA desaturase. The fatty acids that accumulate in livers of SREBP transgenic mice are 18 carbons rather than 16 carbons in length, suggesting that the enzymes required for the elongation of palmitic to stearic acid may be induced. Here, we report the cDNA cloning of a murine long chain fatty acyl elongase (LCE) that was identified initially by oligonucleotide array analysis of mRNA from SREBP transgenic mouse livers. LCE mRNA is highly expressed in liver and adipose tissue. The cDNA encodes a protein of 267 amino acids that shares sequence identity with previously identified very long chain fatty acid elongases. Cells that overexpress LCE show enhanced addition of 2-carbon units to C12-C16 fatty acids. We provide evidence that LCE catalyzes the rate-limiting condensing step in this reaction. The current studies suggest that mouse LCE expression is increased by SREBPs and that the enzyme is a component of the elusive mammalian elongation system that converts palmitic to stearic acid.
In mammals, most of the fatty acids that are synthesized de novo possess chain lengths of 16 -18 carbons. These long chain fatty acids constitute more than 90% of all fatty acids present in cells. They are important components of membranes, and they represent the largest energy storage reservoir in animals.
The highest rate of de novo fatty acid synthesis occurs in liver, which converts excess glucose into fatty acids for storage and transport. Glycolysis converts glucose to pyruvate, which is converted to citrate in the mitochondria and transported to the cytosol. Cytosolic ATP citrate lyase generates acetyl-CoA, the precursor of fatty acids and cholesterol. Acetyl-CoA is carboxylated by acetyl-CoA carboxylase (ACC) 1 to form malonyl-CoA. The multifunction enzyme FAS uses malonyl-CoA, acetyl-CoA, and NADPH to elongate fatty acids in 2-carbon increments (1) . The principal end product of FAS in rodents is palmitic acid, which contains 16 carbons and is designated 16:0 (2). A high proportion of this palmitic acid is then converted to stearate (18:0) .
The mammalian enzymes that elongate palmitic acid to stearic acid have not been identified; however, the elongation activity has been localized to the endoplasmic reticulum (3) . The fatty acid elongase uses malonyl-CoA as the 2-carbon donor. Each 2-carbon addition requires four sequential reactions: 1) condensation between a fatty acyl-CoA and malonyl-CoA to form a 3-ketoacyl-CoA, 2) reduction of the 3-ketoacyl-CoA using NADPH to form a 3-hydroxyacyl-CoA, 3) dehydration of the 3-hydroxyacyl-CoA to trans-2-enoyl-CoA, and 4) reduction of the trans-2-enoyl-CoA to the saturated acyl-CoA (4) .
The biosynthesis of fatty acids and cholesterol are regulated transcriptionally by sterol regulatory element-binding proteins (SREBPs), a family of basic-helix-loop-helix-leucine zipper transcription factors (5) . The three SREBP isoforms are designated SREBP-1a, SREBP-1c, and SREBP-2 (6) . To search for targets of each SREBP in vivo, we previously produced lines of transgenic mice that overexpressed each SREBP isoform in liver (7) (8) (9) . SREBP-1a transgenic mice (TgSREBP-1a) manifested large fatty livers, owing to marked increases in mRNAs encoding lipogenic enzymes, including ϳ20-fold increases in the mRNAs for ACC and FAS (10) . In livers from SREBP-2 transgenic mice (TgSREBP-2), we observed the greatest increases in mRNAs of genes in the cholesterol biosynthetic pathway; however, the mRNAs for FAS and ACC were also significantly elevated (9) . The principal fatty acids that accumulated in livers of both SREBP transgenic mice were 18 carbons in length (10) . These studies suggest that the enzymes responsible for the elongation of palmitic to stearic acids may also be induced in the SREBP transgenic mouse livers.
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The At a molecular level, fatty acid elongases have been characterized most extensively by genetic studies in yeast. Yeast ELO1 elongates C14 to C16 fatty acids and is designated a long chain fatty acid elongase (11) . The ELO2 and ELO3 genes encode very long chain elongases that produce fatty acids of 24 to 26 carbons (12) . The mouse gene, Cig30, encodes the mouse version of ELO2, and Ssc1 encodes the orthologue of ELO3, both of which are very long chain elongases (13) . The animal long chain elongase (equivalent to ELO1) has not yet been identified.
In the current studies, we used Affymetrix GeneChip ® murine arrays hybridized with RNA made from livers of the Tg-SREBP-1a and TgSREBP-2 mice to identify and characterize a mammalian long chain fatty acid elongase. The predicted protein, designated long chain fatty acyl elongase (LCE), shows a sequence resemblance to the very long chain elongases (13) (14) (15) . We show that the mRNA for mouse LCE is induced in SREBP transgenic mouse livers and provide evidence that the enzyme mediates the condensation step that initiates the elongation of C16 to C18 fatty acids in mice.
EXPERIMENTAL PROCEDURES

Materials-[2-
14 C]Malonyl-CoA (40 -60 mCi/mmol) was obtained from PerkinElmer Life Sciences. Redivue [␣-
32 P]dCTP (3000 Ci/mmol) was obtained from Amersham Pharmacia Biotech. All fatty acyl-CoAs, palmitic acid, linoleic acid, linolenic acid, ␥-linolenic acid, arachidonic acid, eicosapentaenoic acid, fatty acid-free BSA, coenzyme A sodium salt, ATP, NADPH, malonyl-CoA, and monoclonal anti-hemagglutinin (HA) (clone number HA-7) were obtained from Sigma.
Affymetrix Oligonucleotide Array Hybridization-Total RNA was prepared from livers of 5 wild-type and 5 age-matched TgSREBP-1a and TgSREBP-2 male mice fed a high protein/low carbohydrate diet for 2 weeks as described (7, 9) . Total RNA was extracted using RNA STAT-60 (Tel-Test, Friendswood, TX). Equal aliquots of total RNA were pooled (20 g) and used for biotin labeling as described in the Affymetrix technical bulletin. Hybridization, washing, scanning, and analysis of the Affymetrix GeneChip ® murine 11K and 19K arrays were carried out as previously described (16) .
Blot Hybridization of RNA-Total RNA was extracted from livers of 5 male wild-type, TgSREBP-1a, and TgSREBP-2 mice as described above. Equal aliquots of total RNA from each mouse liver were pooled (20 g ) and subjected to Northern blot hybridization with the indicated 32 P-labeled cDNA probes as described (7) . The TIGR sequence TC98894 cDNA probe corresponding to mouse LCE (see below) was synthesized by PCR using first strand cDNA made from TgSREBP-1a liver poly(A ϩ ) RNA and the following primers: 5Ј-primer, 5Ј-AGGCAGCTTGGGACT-GAAGA-3Ј; and 3Ј-primer, 5Ј-AGGGTTTAATCTCCGCAGGC-3Ј (7). The cyclophilin probe was synthesized using oligos based on sequence from GenBank accession no. M60456 (5Ј-primer 5Ј-AGCAAGTTC-CATCGTGTCAT-3Ј, and 3Ј-primer 5Ј-AGGGTTTCTCCACTTCGATC-3Ј). Northern blot filters were exposed to a Fuji PhosphorImager and quantified using a Bio-Imaging Analyzer with BAS1000 MacBAS software (Fuji Medical Systems, Stamford, CT).
The Multiple Tissue Northern blot (CLONTECH, catalog no. 7762-1) was used to measure LCE expression in mouse heart, brain, spleen, lung, liver, skeletal muscle, and kidney. For additional tissues, poly(A ϩ ) RNA was isolated using the MESSAGEMAKER mRNA isolation system (Life Technologies, Inc.) from the indicated C57BL/6J mouse tissues. Two g of poly(A ϩ ) RNA from each tissue was subjected to Northern blot hybridization using 32 P-labeled mouse LCE and ␤-actin cDNA probes as described above.
Cloning of Mouse LCE from a SREBP-1a Liver cDNA Library-A bacteriophage cDNA library was made from a TgSREBP-1a mouse liver (7) using the Superscript system for cDNA synthesis and the cloning system (Life Technologies, Inc.). The library was screened by plaque hybridization against 80,000 plaque-forming units in Escherichia coli Y1090(ZL) using a 32 P-labeled TC98894 cDNA probe described above. Six positive plaques were selected for secondary screening and purification. Plasmids containing the selected cDNAs were obtained by infecting E. coli DH10B(ZIP) with the positive lambda phages. The E. coli DH10B(ZIP) express Cre-recombinase, which mediates the excision of the plasmid containing the cDNA from the phage. Positive clones were again identified by colony hybridization using a 32 P-labeled TC98894 probe, and the identified cDNAs were verified by DNA sequencing using an ABI Prism 377 sequencer.
Construction of Mouse LCE and Ssc2 Expression Plasmids-The expression plasmid for mouse LCE was constructed as follows. The full coding region of mouse LCE was generated by PCR using the mouse LCE cDNA as the template and the following primers: 5Ј primer, 5Ј-G-CCACCATGGGCGGCCGCATGAACATGTCAGTGTTGACT-3Ј, which contains a Kozak sequence followed by an ATG codon and a NotI restriction enzyme site; and 3Ј-primer, 5Ј-CTACTCAGCCTTCGTGGCTTT-CTT-3Ј. The resulting PCR product was cloned into pCMV-Script (Stratagene, La Jolla, CA) and designated pCMV-LCE. Plasmid pCMV-LCE was digested with NotI, and three copies of the HA epitope (YPYDVPDYA) were inserted at the 5Ј end of the LCE cDNA. The resulting plasmid was designated pCMV-HA-LCE. The integrity of the PCR product and all ligations was confirmed by DNA sequencing.
The mouse Ssc2 expression plasmid was constructed by PCR amplifying the Ssc2 coding region using first strand cDNA made from Tg-SREBP-1a liver and the following primers: 5Ј-primer, 5Ј-GCCACCAT-GGGCGGCCGCATGGAGCAGCTGAAGGCCTTT-3Ј; and 3Ј-primer, 5Ј-TTATTGAGCCTTCTTGTCCGT-3Ј. The PCR product was cloned into pCMV-Script and designated pCMV-Ssc2. Three copies of the HA epitope sequences were inserted into the NotI site (generated in the PCR reaction) of pCMV-Ssc2, and the integrity of the entire plasmid was confirmed by DNA sequencing. The resulting plasmid was designated pCMV-HA-Ssc2.
Expression of LCE and Ssc2 in Human Embryonic Kidney 293 (HEK-293) Cells-HEK-293
cells were plated at a density of 1.0 ϫ 10 6 cells/ 100-mm dish in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal calf serum, 100 units/ml penicillin G sodium, and 100 g/ml streptomycin sulfate (day 0). On day 1, cells were transfected with 10 g of pCMV-HA-LCE, pCMV-HA-Ssc2, or pCMV-Script plasmids with 1 g of pVAI (17) and 0.6 g of pCMV ␤-galactosidase using 30 l of LipofectAMINE 2000 (Life Technologies, Inc.) according to the manufacturer's instructions. Twenty-four hours after transfection, cytosolic and membrane proteins were isolated. Cells were scraped in 2 ml of PBS, pelleted by centrifugation, and washed one time with 2 ml of PBS. The cells were suspended in 0.25 M sucrose, 10 mM Tris-Cl, pH 7.4, 1 mM EDTA, and a protease inhibitor mixture (2.0 g/ml aprotinin, 5 g/ml pepstatin A, 10 g/ml leupeptin, and 0.5 mM phenylmethylsulfonyl fluoride) and disrupted using a Polytron. Cell homogenates were centrifuged at 600 ϫ g for 10 min at 4°C, the supernatant was collected and centrifuged at 10,000 ϫ g, for 20 min at 4°C. The resulting supernatant was then centrifuged at 1.3 ϫ 10 5 ϫ g (55,000 rpm) for 30 min at 4°C in a Beckman TLA 100.2 rotor, and the pellets were suspended in a buffer that contained 50 mM Tris-Cl, pH 7.4, 1 mM EDTA, 20% glycerol and the protease inhibitor mixture described above. The microsomal protein was stored at Ϫ80°C after snap freezing in liquid nitrogen. Transfection efficiencies were determined by measuring the ␤-galactosidase activity in the supernatant from the 1.3 ϫ 10 5 ϫ g spin using the ␤-galactosidase assay kit (Stratagene, La Jolla, CA).
Expression of HA-tagged LCE and Ssc2 proteins in microsomes from transfected HEK-293 cells was confirmed by immunoblot analysis. Cytosolic and microsomal protein (30 g) was electrophoresed on a 12% SDS-polyacrylamide gel and transferred to Hybond-C nitrocellulose membrane (Amersham Pharmacia Biotech). The membrane was blocked at room temperature for 1 h in PBS, 0.05% Tween 20 (PBST) containing 5% nonfat dried milk, and then incubated with a 1:500 dilution of the primary anti-HA monoclonal antibody (clone HA-7, Sigma) in PBST containing 5% nonfat dried milk for 1 h at room temperature. After washing with PBST, the membrane was incubated with a 1:2000 dilution of horseradish peroxidase-conjugated anti-mouse Ig (Amersham Pharmacia Biotech) for 20 min at room temperature. Washing and immunoblot analysis with SuperSignal CL-HRP substrate (Pierce) was carried out as described (7) . Protein concentrations were determined using the method of Lowry (18) .
In Vitro Fatty Acid Elongation Assay-Fatty acid elongation activity was measured in microsomes prepared from transfected HEK-293 cells using methods similar to those described by Nagi et al. (19) . Fatty acyl-CoAs or BSA-bound fatty acids were used as substrates for all reactions. BSA-bound fatty acids were prepared as 5 or 10 mM solutions as described (20) . Reaction mixtures used to optimize the elongation assay conditions contained 0.1 mg of microsomal protein, 50 mM potassium phosphate, pH 6.5 (except for the pH curve experiment), 5 M rotenone, 40 M palmitoyl-CoA, 60 M [2-14 C]malonyl-CoA (6.5 dpm/ pmol), 1 mM NADPH, and 20 M BSA all in a final volume of 0.2 ml. To establish the optimal pH, 50 mM potassium phosphate buffer was used at pH 5.0, 5.5, 6.0, and 6.5, and 50 mM Tris-Cl buffer was used at pH 7.0, 7.5, 8.0, and 8.5.
Substrate specificity assays with fatty acyl-CoAs contained 0. To initiate the elongation reaction, the assay mixtures were preincubated at 37°C for 1 min, 0.1 mg of microsomal protein from transfected HEK-293 cells was added, and the incubation continued for 10 min. The reactions were stopped by adding 0.2 ml of 5 M KOH, 10% methanol, saponified at 65°C for 1 h, and then acidified by adding 0.2 ml of 5 N HCl and 0.2 ml of ethanol. Fatty acids were collected in three independent extractions using 1 ml of hexane that were pooled in scintillation vials and dried under nitrogen. [ 14 C]Radioactivity was counted and the results expressed as picomoles of [
14 C]malonyl-CoA incorporated into fatty acids.
HPLC Analysis of 14 C-Labeled Fatty Acids-The fatty acid elongation reaction was performed as described above, and extracted fatty acids were suspended in 84.9% methanol, 0.1% acetic acid, and 15% water and separated by reverse phase HPLC using a Hewlett Packard Series 1050 HPLC and a Bio-Rad Bio-Sil C8 90-5 column (150 ϫ 4.6 mm) connected to Hewlett Packard series 1100 refractive index detector and a Foxy 200 fraction collector (ISCO, Lincoln, NB) (21) . The identity of the labeled fatty acids was determined by comparing the retention times with known fatty acid standards.
TLC of Fatty Acid Elongation Intermediates-The fatty acid elongation assay was performed in the presence or absence of 1 mM NADPH using 20 M palmitoyl-CoA as the substrate and 0.1 mg of microsomal protein from pCMV-Script-or pCMV-HA-LCE-transfected HEK-293 cells. Incubations were continued for 0, 2.5, 5, and 10 min in the presence or absence of NADPH. Reactions were terminated and the samples saponified and extracted as described above. Products were evaporated under nitrogen, suspended in 70 l of chloroform, spotted onto LK5DF silica gel 150A TLC plates (Whatman Inc., Clifton, NJ), and separated using hexane:diethylether:acetic acid (30:70:1). Lipids were visualized and quantified by exposing the TLC plate to a Fuji PhosphorImager. The identities of the products were confirmed using authentic standards.
RESULTS
To identify novel SREBP-responsive genes, RNA extracted from livers of TgSREBP-1a and TgSREBP-2 mice was converted into cDNA and hybridized to the GeneChip ® murine 11K and 19K arrays. Working under the hypothesis that SREBP-regulated genes would be expressed at higher levels in both TgSREBP-1a and TgSREBP-2 mouse livers, we chose for further analysis those genes that had the greatest -fold increases in both transgenics. Hybridizations with the 19K array identified a TIGR sequence (TC98894) that was increased 25-and 9-fold, respectively, in livers from TgSREBP-1a and Tg-SREBP-2 mice. To confirm these results, a 32 P-labeled cDNA probe that corresponded to TC98894 was used in Northern blotting of total RNA extracted from wild-type, TgSREBP-1a, and TgSREBP-2 mouse livers (Fig. 1) . The TC98894 probe hybridized to two mRNAs of ϳ2.5 and 6 kb, which were increased 21-and 8.5-fold, respectively, in TgSREBP-1a and Tg-SREBP-2 livers. The -fold increases measured by blotting were similar to those obtained from the oligonucleotide array hybridization.
To facilitate cloning a full-length cDNA corresponding to TC98894, a bacteriophage library was constructed using poly(A ϩ ) RNA isolated from livers of TgSREBP-1a mice. The library was screened by plaque hybridization using a 32 P-labeled TC98894 probe. Six positive plaques were identified and purified. Sequences obtained from the cDNA inserts of all six clones were identical, and the encoded protein was designated LCE. The longest LCE cDNAs contained an in-frame termination codon 21 nucleotides upstream of a putative initiator methionine codon, suggesting that the entire transcriptional reading frame had been obtained.
The gene structure, predicted amino acid sequence, and hydrophobicity plot of the mouse LCE cDNA and protein are shown in Fig. 2 . The sequence of the gene was obtained from the Celera mouse data base as a gene assembly sequence (GA_x5J8B7W6U34). The mouse LCE gene spans ϳ105 kb and has 5 exons and 4 introns (Fig. 2A) . The open reading frame terminates in exon 5. The ϳ6.0-kb mRNA identified by Northern blotting (Fig. 1) includes the entire exon 5 sequence, whereas the ϳ2.5-kb transcript arises from the use of multiple GAAA repeats present within exon 5 as cleavage sites for the addition of polyadenylate. The translational reading frame predicts a 267-amino acid protein (Fig. 2B) . A BLAST search of the NCBI human data base revealed a human cDNA (GenBank accession no. AK027031) that was 92% identical to the mouse LCE cDNA and was predicted to encode a 265-amino acid protein (Fig. 2B) . The predicted mouse and human proteins are 96% identical in sequence, including the motif HXXHH that begins at amino acid 141 in both LCE proteins. This motif is present in previously identified mammalian and yeast desaturase/hydrolase proteins involved in fatty acid elongation (11) (12) (13) 15) . Hydropathy analysis using the Kyte and Doolittle algorithm (22) predicted the presence of as many as five putative transmembrane-spanning domains in mouse LCE (Fig. 2C) .
The amino acid sequence of mouse LCE was used to search the National Institutes of Health data base for related proteins and four mouse proteins, Cig30, Ssc1, Ssc2, and elovl4 were identified (Fig. 3) . As described in the Introduction, the Cig30 and Ssc1 proteins participate in the elongation of very long chain fatty acids (13) . The functions of Ssc2 and elovl4 have not been definitively demonstrated, although it has been suggested FIG. 1. Northern blot analysis of LCE in livers of wild-type, TgSREBP-1a, and TgSREBP-2 mice. Total RNA prepared from livers of wild-type and transgenic mice was used to measure the expression of LCE mRNA as described under "Experimental Procedures". Aliquots (20 g) of pooled total RNA from the livers of 5 male mice were subjected to electrophoresis and blot hybridization with the indicated 32 P-labeled probe. Northern blotting was carried out as described previously (16) . The dried filters were exposed to Kodak X-Omat Blue XB-1 film with intensifying screens at Ϫ80°C for 6 h. The amount of radioactivity in each band was quantified by exposing the filters to a Fuji PhosphorImager and using a Bio-Imaging Analyzer with BAS1000 MacBAS software (Fuji Medical Systems, Stamford, CT). The -fold change relative to that of the wild-type mice was calculated after correction for loading differences with cyclophilin. WT, wild-type; 1a, TgSREBP-1a; 2, TgSREBP-2.
that these proteins also participate in the elongation of very long chain fatty acids (13, 15) . Mouse LCE most closely resembles Cig30 (44% identity). The identities between mouse LCE and Ssc1, Ssc2, and elovl4 are 29, 26, and 26%, respectively. The HXXHH motif is present in all four putative elongases.
To determine the tissue expression pattern of LCE, a com- mercially prepared filter that contained 2 g of poly(A ϩ ) RNA from mouse tissues was hybridized with a 32 P-labeled mouse LCE cDNA probe (Fig. 4, upper panel) . A second filter was prepared that contained 2 g of poly(A ϩ ) RNA from numerous additional tissues isolated from wild-type C57BL/6J mice (Fig.  4, lower panel) . All tissues examined contained LCE mRNA (Fig. 4) , although the spleen, skeletal muscle, and heart had very low levels of this mRNA. The ϳ6.0-kb transcript was the predominant species in all tissues, with the exception of testis, which only contained the shorter ϳ2.5-kb mRNA. Generally, tissues with high lipid content contained high LCE mRNA levels (brown adipose tissue, white adipose tissue, liver, and brain).
To determine whether LCE functions as a fatty acid elongase, HEK-293 cells were transfected with a cDNA encoding mouse LCE that was tagged at its NH 2 terminus with a HA epitope and was expressed under the control of the CMV promoter (pCMV-HA-LCE). As predicted from the hydropathy profiles, immunoblot analysis with an anti-HA antibody revealed that the expressed LCE protein was present only in the microsomal fractions (Fig. 5) . Elongation activity was measured in isolated microsomal membranes and compared with HEK-293 cells transfected with the empty vector alone (pCMV-Script).
Initially, palmitoyl-CoA (16:0) and stearoyl-CoA (18:0) were empirically chosen as the fatty acid substrates in the elongation assay. Elongation was measured as the incorporation of 14 C from [2- 14 C]malonyl-CoA into elongated fatty acid products. Elongation activity was increased in membranes from pCMV-HA-LCE transfected cells when palmitoyl-CoA (16:0) but not stearoyl-CoA (18:0) was used as the substrate (data not shown). Therefore, palmitoyl-CoA was used to optimize the conditions of the elongation reaction prior to testing additional fatty acid substrates (Fig. 6) . The highest rate of [ 14 C]malonylCoA incorporation into fatty acids was measured when the concentration of palmitoyl-CoA in the assay was 20 M (Fig.  6A) . The optimal concentrations of malonyl-CoA and NADPH were ϳ150 M and 1 mM, respectively (Fig. 6, B and C) . As shown by the data of Fig. 6D , LCE exhibited a pH optimum of 6.5. Inasmuch as CoA thioesters of very long chain fatty acids are not available commercially, we tested the substrates as free fatty acids. We included ATP and coenzyme A in the reaction so that the microsomes themselves could synthesize the fatty acyl-CoAs. As a positive control we assayed microsomes from HEK-293 cells transfected with a cDNA encoding Ssc2, which is proposed to be a very long chain elongase (13) . Microsomes from pCMV-HA-LCE-transfected cells showed an increased elongation of C16:0 (solid bars in Fig. 7B ), but no increased activity with fatty acids of longer chain length. On the other hand, expression of Ssc2 led to increased elongation of arachidonic ( and a blot containing six additional tissues made from wild-type C57BL/6J mice (lower panel) were hybridized to a 32 P-labeled LCE cDNA probe as described under "Experimental Procedures." A 6-kb transcript was detected in all tissues except testis. A 2.5-kb mRNA transcript was detected in liver, kidney, testis, white adipose tissue (WAT), brown adipose tissue (BAT), small intestine (Sm. Int.), and adrenal gland. The blots were stripped and re-hybridized with a ␤-actin probe to indicate mRNA was present in each lane.
FIG. 5.
Expression of HA-tagged mouse LCE in cytosol and membrane fractions of transfected HEK-293 cells. Cultured HEK-293 cells were set up on day 0 and transfected on day 1 as described under "Experimental Procedures." Cells were transiently transfected with the HA-tagged LCE cDNA expression plasmid (pCMV-HA-LCE) or the vector alone (pCMV-Script). On day 2, the cells were harvested and cytosolic and membrane fractions isolated. Aliquots (30 g) of cytosolic (C) and membrane (M) protein were subjected to SDS-polyacrylamide gel electrophoresis and immunoblot analysis with 1:500 dilution of an anti-HA monoclonal antibody. The filter was exposed to film for 5 s at room temperature.
in Fig. 7B ). This latter result demonstrates that the longer chain fatty acids were indeed activated to the CoA thioesters during the reaction.
The fatty acids produced in the elongation assay were next analyzed by HPLC. The data of Fig. 8 show the fatty acid products obtained from microsomes of pCMV-HA-LCE-transfected HEK-293 cells incubated with lauroyl-CoA (12:0), myristoyl-CoA (14:0), or palmitoyl-CoA (16:0). In reactions containing lauroyl-CoA (12:0) as a substrate, myristic acid (14:0) was the major product. Smaller but significant amounts of palmitic (16:0) and stearic (18:0) fatty acids were also produced, indicating that additional elongation rounds were occurring (Fig.  8A) . Similarly, when myristoyl-CoA (14:0) or palmitoyl-CoA (16:0) fatty acids were used as the substrates, the principal products were saturated fatty acids containing two additional carbons (Fig. 8, B and C) .
To confirm that LCE could carry out the first step of the elongation reaction (condensation of fatty acyl-CoA and malonyl-CoA), we measured the elongation intermediates that were produced in microsomes incubated without NADPH (Fig. 9) . In the absence of NADPH, the two reduction steps in fatty acid elongation cannot proceed; therefore, the only labeled product that can accumulate under this condition is the product of the initial condensation step, i.e. 3-ketostearoyl-CoA. As shown in Fig. 8 , this product was increased ϳ6 -8-fold in LCE transfected microsomes incubated in the absence of NADPH ( lanes  1-4 versus 9 -12 ). In the presence of NADPH, the elongation reaction proceeded to completion with the formation of stearic acid (Fig. 9, lanes 5-8 versus 13-16 ).
DISCUSSION
In the current studies, we utilized oligonucleotide arrays to identify a new SREBP-regulated gene that encodes a ratelimiting component of the long chain fatty acyl elongase reaction. This enzyme specifically catalyzes the elongation of fatty acids with 12, 14, and 16 carbons. It does not elongate the C:18 fatty acids or very long chain fatty acids. Mouse LCE appears to be an integral membrane protein containing five transmembrane domains, a characteristic shared by previously identified yeast and mouse elongase enzymes (12, 13, 15) . Mouse LCE contains a histidine-rich motif (HXXHH) that is present in the previously described very long chain fatty acid elongases (3, 12, 13, 15) .
The first mammalian elongation enzyme described, Cig30, was initially identified as a protein induced in brown adipose tissue when mice were exposed to cold (14) . Ssc1 and Ssc2 were isolated subsequently based on homology to Cig30 (13) . Insight into their function was derived from homologies to the yeast ELO family of genes (ELO1, ELO2, and ELO3). In yeast, ELO1 elongates C14 fatty acids to C16 fatty acids (11) , and ELO2 and ELO3 are required for the synthesis of very long chain fatty acids of up to 24 and 26 carbons, respectively (12) . Complementation studies in yeast mutants revealed that Ssc1 was the functional equivalent of ELO3, and that Cig30 was functionally equivalent to ELO2. A specific elongase activity has not been assigned to Ssc2, although in complementation studies this enzyme did not substitute for yeast ELO1 (13) . In the current studies, we provide evidence that at least two substrates for mouse Ssc2 are arachidonic ( acids. ELOVL4, a gene identified by linkage and haplotype analysis in families with two forms of autosomal dominant macular dystrophy (15) , encodes a protein that is 44% identical to Ssc2. The mRNA for ELOVL4 is expressed only in the retina, brain, and testis, all of which are tissues with high contents of very long chain fatty acids. The function of elovl4 has not been determined; however, based on the tissue distribution of ELOVL4 and the phenotype observed when mutated, it is assumed that ELOVL4 is involved in the elongation of very long chain fatty acids.
The extreme hydrophobicity of the identified elongase proteins has prevented their purification and the characterization of their precise roles in fatty acid elongation. It has been suggested that these proteins are involved in the intermediate steps, notably the reduction of 3-ketoacyl-CoA and/or trans-2-enoyl-CoA (13) . Support for this assumption is derived from the following observations. 1) The histidines present in the HXXHH motif may act together with aspartate and glutamate to coordinate an Fe-O-Fe cofactor to receive electrons from either cytochrome b 5 or a cytochrome b 5 -like domain in an NAD(P)H-dependent manner (23, 24) ; and 2) the condensing enzymes for very long chain fatty acid elongation in plants share no sequence similarity with the currently identified yeast and mouse elongase proteins. cDNAs encoding condensing enzymes have been cloned from Arabidopsis (25, 26) , jojoba (27) , and Brassica (28) . The substrate specificities exhibited by the plant condensing enzymes are analogous to those described for the identified yeast and mammalian elongase proteins. This similarity has led others to speculate that Cig30, Scc1, and Ssc2 may represent rate-limiting condensing enzymes in yeast and mammals (29) .
We present evidence that LCE is a condensing enzyme in the elongation system. First, in the absence of NADPH, microsomes prepared from cells transfected with a mouse LCE expression vector had ϳ6-fold higher elongation activity than those from cells transfected with the vector alone (Fig. 6C) . The condensation step is rate-limiting in fatty acid elongation; therefore, the higher elongation activity in LCE-transfected microsomes suggests that LCE may be the rate-limiting condensing enzyme. Second, microsomes transfected with mouse LCE and incubated with palmitoyl-CoA in the absence of NADPH accumulate only one product, identified as 3-ketostearoyl-CoA (Fig. 9) . The amount of 3-ketostearoyl-CoA produced in the transfected microsomes was 6 -8-fold higher than that in control microsomes, which is the same increase observed in the synthesis of the end product stearic acid when NADPH was included in the reaction. Whether LCE can also carry out sequential steps in the fatty acid elongation reaction could not be determined with the assay at hand. Further confirmation of the condensing properties of LCE will require purification of the enzyme. The fatty acid substrates elongated by mouse LCE overlap with those of cytosolic FAS, with the important exception of palmitic acid. In rodents, it is estimated that 90% of the endogenously synthesized stearate occurs through the elongation of palmitate in the endoplasmic reticulum and not through cytosolic FAS (2) . The data presented suggest that LCE is a member of the elusive elongation system present in the endoplasmic reticulum of mammals that is likely responsible for elongation of palmitic acid to stearic acid in vivo. Whether LCE is essential for the elongation of palmitic acid or whether FAS is also capable of carrying out this function in vivo will have to await further analysis in mice that lack the LCE enzyme.
The increased expression of LCE in the livers of SREBP transgenic mice (Fig. 1) suggests strongly that this gene is a direct transcriptional target of these factors. This suggestion is supported by the finding that mice lacking active nuclear forms of SREBPs in liver because of the elimination of SREBP cleavage-activating protein express reduced (50% decline) LCE mRNA levels. 2 In addition, analysis of the mouse LCE promoter sequence identified in the Celera data base revealed a potential SREBP binding sequence (TCATGCCAG) located 364 base pairs upstream of exon 1 of the gene. In all promoters studied to date, SREBP-mediated activation also requires the interaction of SREBP with a second transcription factor such as NF-Y or Sp1 (30 -34) . A potential NF-Y binding site is present in the mouse LCE promoter 25 base pairs downstream of this SREBP binding site. Finally, SREBPs mediated the coordinate regulation of enzyme cascades required for the production of cholesterol and monounsaturated fatty acids; therefore, the enzymes required for elongation of palmitic to stearic acid are rational SREBP target genes.
Microarray analysis is a powerful tool to evaluate the expression of many genes in various experimental systems and is particularly suited to the identification of target genes for transcription factors. We have taken advantage of SREBP transgenic mice to identify an SREBP-regulated gene that elongates long chain fatty acids. A full description of other regulated genes identified using the GeneChip ® Murine 11K and 19K arrays is forthcoming. 3 
